{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:07:19Z","timestamp":1792789639263,"version":"4.5.0"},"reference-count":52,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19gm0710005"],"award-info":[{"award-number":["JP19gm0710005"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21gm0910013"],"award-info":[{"award-number":["JP21gm0910013"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21gm1010010"],"award-info":[{"award-number":["JP21gm1010010"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"award":["JP19gm0710005"],"award-info":[{"award-number":["JP19gm0710005"]}],"id":[{"id":"https:\/\/ror.org\/004rtk039","id-type":"ROR","asserted-by":"publisher"}]},{"award":["JP21gm0910013"],"award-info":[{"award-number":["JP21gm0910013"]}],"id":[{"id":"https:\/\/ror.org\/004rtk039","id-type":"ROR","asserted-by":"publisher"}]},{"award":["JP21gm1010010"],"award-info":[{"award-number":["JP21gm1010010"]}],"id":[{"id":"https:\/\/ror.org\/004rtk039","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["25K11804"],"award-info":[{"award-number":["25K11804"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Manpei Suzuki Diabetes Foundation","id":[{"id":"https:\/\/ror.org\/03pkewe16","id-type":"ROR","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/03pkewe16","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Japan Diabetes Foundation","id":[{"id":"https:\/\/ror.org\/002cfy541","id-type":"ROR","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/002cfy541","id-type":"ROR","asserted-by":"publisher"}]},{"name":"MEXT Cooperative Research Project Program"},{"name":"Medical Research Center Initiative for High Depth Omics"},{"DOI":"10.13039\/501100004096","name":"Medical Institute of Bioregulation (MIB), Kyushu University","doi-asserted-by":"publisher","award":["JPMXP1323015486"],"award-info":[{"award-number":["JPMXP1323015486"]}],"id":[{"id":"10.13039\/501100004096","id-type":"DOI","asserted-by":"publisher"}]},{"award":["JPMXP1323015486"],"award-info":[{"award-number":["JPMXP1323015486"]}],"id":[{"id":"https:\/\/ror.org\/00p4k0j84","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Patients with diabetes often develop abnormalities in lipid metabolism that can promote diabetic complications. Lipidomic studies have demonstrated that certain plasma lipid species are associated with the development of cardiovascular diseases. However, the plasma lipids associated with endothelial dysfunction remain unclear. To identify the lipids associated with flow-mediated vasodilation (FMD), an indicator of endothelial function, in patients with diabetes, we performed a cross-sectional analysis as a subanalysis of a previous lipidomic study. In total, 200 patients with type 2 diabetes were included in the analysis. A total of 55.0% were men, and the mean age (\u00b1standard deviation) was 61.1 \u00b1 11.3 years. Their HbA1c and FMD values were 9.04 \u00b1 1.79% (75.3 \u00b1 19.5 mmol\/mol) and 5.77 \u00b1 2.55%, respectively. Supercritical fluid chromatography\/mass spectrometry-based semi-targeted lipidomic analysis identified 349 lipids belonging to 16 lipid classes. We selected 13 distinctive lipids potentially associated with FMD, according to a sparse-group least absolute shrinkage and selection operator regularized regression model. Of these, seven phospholipids, including three phosphatidylethanolamine (PE) plasmalogens and three phosphatidylinositols (PIs), showed a positive association with FMD after adjusting for atherosclerotic risk factors. These findings may contribute to improving the assessment and management of endothelial dysfunction in patients with diabetes.<\/jats:p>","DOI":"10.3390\/ijms27198437","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:32:12Z","timestamp":1790083932000},"page":"8437","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma Lipids Associated with Endothelial Dysfunction in Patients with Type 2 Diabetes: A Cross-Sectional Study Using Lipidomic Analysis"],"prefix":"10.3390","volume":"27","author":[{"given":"Naohiro","family":"Taya","sequence":"first","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka, 2-2, Yamadaoka, Suita 565-0871, Osaka, Japan"},{"name":"Department of Diabetes Care Medicine, Graduate School of Medicine, The University of Osaka, 2-2, Yamadaoka, Suita 565-0871, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9020-8320","authenticated-orcid":false,"given":"Naoto","family":"Katakami","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka, 2-2, Yamadaoka, Suita 565-0871, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"}]},{"given":"Kazuo","family":"Omori","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka, 2-2, Yamadaoka, Suita 565-0871, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"}]},{"given":"Shigero","family":"Hosoe","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka, 2-2, Yamadaoka, Suita 565-0871, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5105-041X","authenticated-orcid":false,"given":"Mitsuyoshi","family":"Takahara","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka, 2-2, Yamadaoka, Suita 565-0871, Osaka, Japan"},{"name":"Department of Laboratory Medicine, Graduate School of Medicine, The University of Osaka, 2-2, Yamadaoka, Suita 565-0871, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]},{"given":"Kazuyuki","family":"Miyashita","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka, 2-2, Yamadaoka, Suita 565-0871, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3696-7809","authenticated-orcid":false,"given":"Shugo","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka, 2-2, Yamadaoka, Suita 565-0871, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"validation","vocabulary":"credit"}]},{"given":"Yutaka","family":"Konya","sequence":"additional","affiliation":[{"name":"Division of Metabolomics, Medical Research Center for High Depth Omics, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Sachiko","family":"Obara","sequence":"additional","affiliation":[{"name":"Division of Metabolomics, Medical Research Center for High Depth Omics, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Ayako","family":"Hidaka","sequence":"additional","affiliation":[{"name":"Division of Metabolomics, Medical Research Center for High Depth Omics, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Motonao","family":"Nakao","sequence":"additional","affiliation":[{"name":"Division of Metabolomics, Medical Research Center for High Depth Omics, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Masatomo","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of Metabolomics, Medical Research Center for High Depth Omics, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Fukuoka, Japan"},{"name":"Mass Spectrometry Center, Graduate School of Science, The University of Osaka, 1-1 Machikaneyama, Toyonaka 560-0043, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4608-4652","authenticated-orcid":false,"given":"Yoshihiro","family":"Izumi","sequence":"additional","affiliation":[{"name":"Division of Metabolomics, Medical Research Center for High Depth Omics, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Fukuoka, Japan"},{"name":"Mass Spectrometry Center, Graduate School of Science, The University of Osaka, 1-1 Machikaneyama, Toyonaka 560-0043, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Takeshi","family":"Bamba","sequence":"additional","affiliation":[{"name":"Division of Metabolomics, Medical Research Center for High Depth Omics, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Fukuoka, Japan"},{"name":"Laboratory of Systems Metabolomics, Graduate School of Medicine, The University of Osaka, 2-2, Yamadaoka, Suita 565-0871, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"}]},{"given":"Iichiro","family":"Shimomura","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka, 2-2, Yamadaoka, Suita 565-0871, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Emerging Risk Factors Collaboration, Sarwar, N., Gao, P., Seshasai, S.R., Gobin, R., Kaptoge, S., Di Angelantonio, E., Ingelsson, E., Lawlor, D.A., and Selvin, E. (2010). Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet, 375, 2215\u20132222. Correction in Lancet\u00a02010, 376, 958.","DOI":"10.1016\/S0140-6736(10)60484-9"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41569-023-00877-z","article-title":"Cardiovascular risk in diabetes mellitus: Epidemiology, assessment and prevention","volume":"20","author":"Wong","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","article-title":"Clinical update: Cardiovascular disease in diabetes mellitus: Atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus\u2014Mechanisms, management, and clinical considerations","volume":"133","author":"Wang","year":"2016","journal-title":"Circulation"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41569-024-01115-w","article-title":"Atherosclerosis in diabetes mellitus: Novel mechanisms and mechanism-based therapeutic approaches","volume":"22","author":"Khan","year":"2025","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41569-025-01162-x","article-title":"Endothelial cell metabolism in cardiovascular physiology and disease","volume":"22","author":"Pasut","year":"2025","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s12291-015-0516-y","article-title":"Endothelial dysfunction in type 2 diabetes mellitus","volume":"31","author":"Dhananjayan","year":"2016","journal-title":"Indian J. Clin. Biochem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0002-9149(01)02051-3","article-title":"Usefulness of flow-mediated dilation of the brachial artery and\/or the intima-media thickness of the carotid artery in predicting coronary narrowing in patients suspected of having coronary artery disease","volume":"88","author":"Teragawa","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1093\/eurheartj\/ehz350","article-title":"Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans","volume":"40","author":"Thijssen","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial function and dysfunction: Testing and clinical relevance","volume":"115","author":"Deanfield","year":"2007","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1067\/mhj.2000.108508","article-title":"Flow-mediated vasoactivity and circulating adhesion molecules in hypertriglyceridemia: Association with small, dense LDL cholesterol particles","volume":"140","author":"Lupattelli","year":"2000","journal-title":"Am. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.atherosclerosis.2011.04.019","article-title":"Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction","volume":"217","author":"Yunoki","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"102370","DOI":"10.1016\/j.cbpa.2023.102370","article-title":"Recent advances towards mass spectrometry-based clinical lipidomics","volume":"76","author":"Salihovic","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"McGranaghan, P., Kirwan, J.A., Garcia-Rivera, M.A., Pieske, B., Edelmann, F., Blaschke, F., Appunni, S., Saxena, A., Rubens, M., and Veledar, E. (2021). Lipid metabolite biomarkers in cardiovascular disease: Discovery and biomechanism translation from human studies. Metabolites, 11.","DOI":"10.3390\/metabo11090621"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kale, D., Fatangare, A., Phapale, P., and Sickmann, A. (2023). Blood-derived lipid and metabolite biomarkers in cardiovascular research from clinical studies: A recent update. Cells, 12.","DOI":"10.3390\/cells12242796"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"167806","DOI":"10.1016\/j.bbadis.2025.167806","article-title":"Lipidomics and cardiovascular disease","volume":"1871","author":"Surendran","year":"2025","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Mol. Basis Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1161\/ATVBAHA.116.307497","article-title":"Circulating ceramides predict cardiovascular outcomes in the population-based FINRISK 2002 cohort","volume":"36","author":"Havulinna","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","article-title":"Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol","volume":"37","author":"Laaksonen","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e85724","DOI":"10.1371\/journal.pone.0085724","article-title":"Glycerophospholipid and sphingolipid species and mortality: The Ludwigshafen Risk and cardiovascular Health (LURIC) study","volume":"9","author":"Sigruener","year":"2014","journal-title":"PLoS ONE"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/cvr\/cvaf093","article-title":"Ceramides in cardiovascular disease: Emerging role as independent risk predictors and novel therapeutic targets","volume":"121","author":"Klingenberg","year":"2025","journal-title":"Cardiovasc. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e48341","DOI":"10.1097\/MD.0000000000048341","article-title":"Association between plasma ceramide levels and endothelial dysfunction in patients with acute coronary syndrome: A prospective observational study","volume":"105","author":"Chen","year":"2026","journal-title":"Medicine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.5551\/jat.52506","article-title":"Identification of plasma inositol and indoxyl sulfate as novel biomarker candidates for atherosclerosis in patients with type 2 diabetes. -Findings from Metabolome Analysis Using GC\/MS-","volume":"27","author":"Omori","year":"2020","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1161\/HYPERTENSIONAHA.118.11554","article-title":"Physiological Diagnosis Criteria for Vascular Failure Committee. Physiological diagnostic criteria for vascular failure","volume":"72","author":"Tanaka","year":"2018","journal-title":"Hypertension"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12933-018-0763-3","article-title":"Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: Molecular insights and therapeutic strategies","volume":"17","author":"Kaur","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.febslet.2005.02.018","article-title":"Formation of ceramide-enriched domains in lipid particles enhances the binding of apolipoprotein E","volume":"579","author":"Morita","year":"2005","journal-title":"FEBS Lett."},{"key":"ref_26","first-page":"169","article-title":"Effects of sphingomyelin on apolipoprotein E- and lipoprotein lipase-mediated cell uptake of lipid particles","volume":"1631","author":"Morita","year":"2003","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Mol. Cell Biol. Lipids"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40780-024-00344-y","article-title":"Phospholipid biomarkers of coronary heart disease","volume":"10","author":"Morita","year":"2024","journal-title":"J. Pharm. Health Care Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1161\/01.ATV.19.10.2431","article-title":"Role of plasmalogens in the enhanced resistance of LDL to copper-induced oxidation after LDL apheresis","volume":"19","author":"Hahnel","year":"1999","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1194\/jlr.M200340-JLR200","article-title":"Ethanolamine plasmalogens prevent the oxidation of cholesterol by reducing the oxidizability of cholesterol in phospholipid bilayers","volume":"44","author":"Maeba","year":"2003","journal-title":"J. Lipid Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5551\/jat.14.12","article-title":"Plasmalogens in human serum positively correlate with high-density lipoprotein and decrease with aging","volume":"14","author":"Maeba","year":"2007","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1161\/ATVBAHA.111.234096","article-title":"Plasma lipidomic analysis of stable and unstable coronary artery disease","volume":"31","author":"Meikle","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"105551","DOI":"10.1016\/j.ebiom.2024.105551","article-title":"Mid-life anti-inflammatory metabolites are inversely associated with long-term cardiovascular disease events","volume":"112","author":"Saeed","year":"2025","journal-title":"eBioMedicine"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Huang, Y., Mu, R., Wen, D., Grimsby, J.S., Liang, M., and Rosenbaum, A.I. (2021). Differences in levels of phosphatidylinositols in healthy and stable coronary artery disease subjects revealed by HILIC-MRM method with SERRF normalization. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0252426"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Qian, Y., Sun, Z., Shen, X., Cai, Y., Li, L., and Wang, Z. (2021). Role of PI3K in the progression and regression of atherosclerosis. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.632378"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11883-025-01364-1","article-title":"The role of the PI3K\/Akt\/mTOR pathway in atherosclerosis: Mechanisms, therapeutic potential, and emerging targeted treatments","volume":"27","author":"Zhang","year":"2025","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jacl.2023.07.005","article-title":"Diet-derived and diet-related endogenously produced palmitic acid: Effects on metabolic regulation and cardiovascular disease risk","volume":"17","author":"Annevelink","year":"2023","journal-title":"J. Clin. Lipidol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: Mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1161\/CIRCRESAHA.124.324383","article-title":"Emerging roles and therapeutic applications of arachidonic acid pathways in cardiometabolic diseases","volume":"135","author":"Hu","year":"2024","journal-title":"Circ. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1161\/CIRCULATIONAHA.118.038908","article-title":"Biomarkers of dietary omega-6 fatty acids and incident cardiovascular disease and mortality: An individual-level pooled analysis of 30 cohort studies","volume":"139","author":"Marklund","year":"2019","journal-title":"Circulation"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Krajnik, A., Brazzo, J.A., Vaidyanathan, K., Das, T., Redondo-Mu\u00f1oz, J., and Bae, Y. (2020). Phosphoinositide signaling and mechanotransduction in cardiovascular biology and disease. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.595849"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","article-title":"International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force","volume":"39","author":"Corretti","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/ajh.2011.55","article-title":"Relationships among hyperuricemia, metabolic syndrome, and endothelial function","volume":"24","author":"Tomiyama","year":"2011","journal-title":"Am. J. Hypertens."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.5551\/jat.44859","article-title":"Association between subclinical atherosclerosis markers and the level of accumulated advanced glycation end-products in the skin of patients with diabetes","volume":"25","author":"Ninomiya","year":"2018","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Taya, N., Katakami, N., Omori, K., Hosoe, S., Watanabe, H., Takahara, M., Miyashita, K., Konya, Y., Obara, S., and Hidaka, A. (2025). Plasma diacylglycerols are associated with carotid intima-media thickness among patients with type 2 diabetes: Findings from a supercritical fluid chromatography\/mass spectrometry-based semi-targeted lipidomic analysis. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26146977"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/jdi.13924","article-title":"Change in fatty acid composition of plasma triglyceride caused by a 2 week comprehensive risk management for diabetes: A prospective observational study of type 2 diabetes patients with supercritical fluid chromatography\/mass spectrometry-based semi-target lipidomic analysis","volume":"14","author":"Taya","year":"2023","journal-title":"J. Diabetes Investig."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/rcm.7862","article-title":"Wide target analysis of acylglycerols in miso (Japanese fermented soybean paste) by supercritical fluid chromatography coupled with triple quadrupole mass spectrometry and the analysis of the correlation between taste and both acylglycerols and free fatty acids","volume":"31","author":"Ogawa","year":"2017","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"11997","DOI":"10.1021\/acs.jafc.0c04723","article-title":"Dynamic metabolome analysis reveals the metabolic fate of medium-chain fatty acids in AML12 cells","volume":"68","author":"Fushimi","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1194\/jlr.D083014","article-title":"Widely-targeted quantitative lipidomics method by supercritical fluid chromatography triple quadrupole mass spectrometry","volume":"59","author":"Takeda","year":"2018","journal-title":"J. Lipid Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/10618600.2012.681250","article-title":"A sparse-group lasso","volume":"22","author":"Simon","year":"2013","journal-title":"J. Comput. Graph. Stat."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2200334","DOI":"10.1002\/bimj.202200334","article-title":"Sparse group penalties for bi-level variable selection","volume":"66","author":"Buch","year":"2024","journal-title":"Biom. J."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8437\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:18:13Z","timestamp":1790223493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":52,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["ijms27198437"],"URL":"https:\/\/doi.org\/10.3390\/ijms27198437","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]}}}